Neurological disorders in patients with bullous pemphigoid

Dermatology

Volumn 215, Issue 3, 2007, Pages 187-191

  Cordel, Nadège ^a,j   Chosidow, Olivier ^b   Hellot, Marie France ^c   Delaporte, Emmanuel ^d   Lok, Catherine ^e   Vaillant, Loïc ^f   Bernard, Philippe ^g   D'Incan, Michel ^h   Roujeau, Jean Claude ⁱ   Joly, Pascal ^a  

^a University of the French West Indies   (Guadeloupe)

^b HÔPITAL TENON   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g REIMS UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

ⁱ UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

^j Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

more..

Author keywords

Bullous pemphigoid; Dementia; Neurological disorders

Indexed keywords

AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STROKE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; NERVOUS SYSTEM DISEASES; PEMPHIGOID, BULLOUS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 34548496643     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106574     Document Type: Article

References (30)

1. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, et al: Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995;131:48-52.
2. Zillikens D, Wever S, Roth A, Haschimoto T, Brocker EB: Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957-958.
3. Vaillant L, Bernard P, Joly P, Prost C, Labeille B, et al: Evaluation of clinical criteria for diagnosis of bullous pemphigoid. Arch Dermatol 1998;134:1075-1080.
4. Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, et al: Drugs associated with bullous pemphigoid: a case-control study. Arch Dermatol 1996;132:272-276.
5. Joly P, Roujeau P, Benichou P, Picard C, Dreno B, Delaporte E, et al: A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321-327.
6. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, et al: High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998;134:465-469.
7. Obadia Y, Rotily M, Degrand-Guillaud A, Guelain J, Ceccaldi M, Severo C, et al: The PREMAP Study: prevalence and risk factors of dementia and clinically diagnosed Alzheimer's disease in Provence, France. Eur J Epidemiol 1997;3:247-253.
8. Joly P, Benichou J, Lok C, Hellot MF, Saiag P, et al: Prediction of survival in patients with bullous pemphigoid. Arch Dermatol 2005;141:1-8.
9. Masouyé I, Schmied E, Didierjean L, Abba Z, Saurat JH: Bullous pemphigoid and multiple sclerosis: more than a coincidence? J Am Acad Dermatol 1989;21:63-68.
10. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F: Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995;20:449-453.
11. Stinco G, Mattighello P, Zanchi M, Patrone P: Multiple sclerosis and bullous pemphigoid: a casual association or a pathogenic correlation? Eur J Dermatol 2002;2:186-188.
12. Foureur N, Descamps V, Lebrun-Vignes, Picard-Dahan C, Grossin M, Belaich S, et al: Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid ? Eur J Dermatol 2001;3:230-233.
13. Chosidow O, Doppler V, Bensimon G, Joly P, Salachas F, Lacomblez L, et al: Bullous pemphigoïd and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol 2000;136:521-524.
14. Folstein MF, Folstein SE, McHugh PR: Minimental-state: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975;12:189-198.
15. Crooks V, Waller S, Smith T, Hahn TJ: The use of Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991;46:M139-M144.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Guo L, Degenstein L, Dowling J, Yu KC, Wollmann R, Perman B: Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995;81:223-243.
18. Laffite E, Burkhard PR, Fontao L, Jaunin F, Saurat JH, Chofflon M, et al: Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis. Br J Dermatol 2005;152:537-540.
19. Dartigues JF, Orgogozo JM, Letenneur L, Barbeger-Gateau P: French epidemiological bases for the treatment of dementia syndromes and cognitive impairment in the elderly. Therapie 1993;3:185-187.
20. Letenneur L, Dequae L, Jacqmin H, Nuissier J, Decamps A, Barbeger-Gateau P, et al: Prevalence of dementia in Gironde (France). Rev Epidemiol Santé Publ 1993;2:139-145.
21. Schoenberg BS, Anderson DW, Haerer AF: Severe dementia: prevalence and clinical features in a biracial US population. Arch Neurol 1985;42:740-743.
22. Pfeffer RJ, Afifi AA, Chance JM: Prevalence of Alzheimer's disease in a retirement community. Am J Epidemiol 1987;125:420-436.
23. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al: Prevalence of Alzheimer disease in a community population of older persons. JAMA 1989;262:2551-2556.
24. Folstein MF, Basset SS, Anthony JC, Romanoski AJ, Nestadt GR: Dementia: case ascertainment in a community survey. J Gerontol 1991;46:M132-M138.
25. Heyman A, Fillenbaum G, Prostnitz B, Raiford K, Burchett B, Clark C: Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol 1991;48:594-598.
26. Perkins P, Anmegers JF, Doody RS, Cooke N, Aday L, Vernon SW: Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44-50.
27. Husaini BA, Sherkat DE, Moonis M, Levine R, Holzer C, Cain VA: Racial differences in the diagnosis of dementia and its effects on the use and costs of health care services. Psychiatr Serv 2003;54:92-96.
28. Rzany B, Partscht K, Jung M, et al: Risk for lethal outcome in patients with bullous pemphigoid. Arch Dermatol 2002;138:903-908.
29. Colbert RL, Allen DM, Eastwood D, Fairley JA: Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 2004;122:1091-1095.
30. Joly P, Benichou J, Saiag P, Bernard P, Roujeau JC: Response to mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 2005;124:664-665.